Latest diabetic neuropathy Stories
XTend Medical has secured the exclusive global distribution rights to DDI's vibration device for pre-screening of diabetic neuropathy.
Immunosyn Corporation (OTCBB:IMYN) announced today that marketing, distribution and patient treatment approval has been granted by the Ministry of Health Malaysia for SF-1019 in the Private Pay Heath Sector in Malaysia. The marketing name for SF-1019 in Malaysia will be R-1818.
The Stanford University Center on Longevity and the U.S.
SAN MATEO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. , a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will report results for its second quarter 2008 on Wednesday, August 13, 2008, after the market closes.
RICHMOND, Calif., July 23 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. today reported second quarter 2008 financial results and accomplishments.
XTL Biopharmaceuticals has completed patient randomization into its Phase IIb study of Bicifadine - a serotonin and norepinephrine reuptake inhibitor - for the treatment of diabetic neuropathic pain. Approximately 350 patients were randomized into the study.
By Napoli, Maryann Many people with diabetes suffer from a painful condition called peripheral neuropathy. The burning, numbness, tingling and throbbing sensations that primarily affect the feet are notoriously resistant to successful treatment.
By Papanas, N Symeonidis, G; Mavridis, G; Georgiadis, G S; Papas, T T; Lazarides, M K; Maltezos, E Aim. The aim of this study was to investigate the potential role of ankle-brachial index (ABI) as a marker of microvascular disease in patients with type 2 diabetes mellitus. Methods.
NEW YORK (Reuters Health) - In more cases than would normally be expected, people who develop type 2 diabetes have a history of carpal tunnel syndrome. The wrist nerve problem sometimes predates the onset of diabetes by up to 10 years, according to a UK study. Led by Dr. Martin C.
By Karla Gale SAN DIEGO (Reuters Health) - Injections of botulinum toxin A relieve pain in an animal model of diabetic neuropathy, according to research reported at the American Academy of Neurology's annual meeting in San Diego.
- The act of sweetening by admixture of some saccharine substance.